BIOGENETICS CLINICAL RESEARCH Trademark

Trademark Overview


On Monday, June 12, 2023, a trademark application was filed for BIOGENETICS CLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the BIOGENETICS CLINICAL RESEARCH trademark a serial number of 98038193. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 5, 2024. This trademark is owned by BIOGENETICS CLINICAL RESEARCH Corp.. The BIOGENETICS CLINICAL RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services
biogenetics clinical research

General Information


Serial Number98038193
Word MarkBIOGENETICS CLINICAL RESEARCH
Filing DateMonday, June 12, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOGENETICS CLINICAL RESEARCH Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHomestead, FL 33032

Trademark Events


Event DateEvent Description
Thursday, June 15, 2023NEW APPLICATION ENTERED
Sunday, July 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 1, 2024ASSIGNED TO EXAMINER
Tuesday, March 5, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 5, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED